R18.0
BillableMalignant ascites
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is R18.0 an HCC code?
Yes. R18.0 maps to Metastatic Cancer and Acute Leukemia under the CMS-HCC V28 risk adjustment model.
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for R18.0
For R18.0to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed R18.0 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
R18.0 is the ICD-10-CM diagnosis code for malignant ascites. Abnormal fluid accumulation in the abdominal cavity that is related to cancer or malignancy. R18.0 sits in the ICD-10-CM chapter for symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (r00-r99), within the section covering symptoms and signs involving the digestive system and abdomen (r10-r19).
Under the CMS-HCC V28 risk adjustment model, R18.0 maps to Metastatic Cancer and Acute Leukemia (HCC 17) with a community, non-dual, aged base RAF weight of 0.368. R18.0 was not retained as a payment HCC under the older V24 model, so V28 introduced or recategorized it during the 2024–2026 phase-in. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Always code the underlying malignancy in addition to this code. Because R18.0 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for R18.0 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Always code the underlying malignancy in addition to this code
- •This code indicates ascites secondary to a neoplastic process
Clinical Significance
Malignant ascites represents fluid accumulation in the peritoneal cavity specifically related to cancer, indicating advanced malignancy with peritoneal involvement or carcinomatosis. This condition has significant prognostic implications and requires palliative management including paracentesis, diuretics, and comfort care measures.
Documentation Requirements
- ✓Documentation of ascites with malignant etiology
- ✓Underlying malignancy identified
- ✓Cytological confirmation of malignant cells in fluid if performed
- ✓Clinical evidence of carcinomatosis
- ✓Paracentesis procedures and results
- ✓Response to treatment measures
- ✓Associated symptoms (abdominal distension, discomfort)
- ✓Prognosis and care planning